ACT vs KOD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ACT · Enact Holdings$46.43 ▼ 2.81%
KOD · Kodiak Sciences$99.30 ▲ 9.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ACT +26.8%
- KOD +437.0%
Head to head
| Metric | ACT | KOD |
|---|---|---|
| Price | $46.43 | $99.30 |
| Change today | ▼ 2.81% | ▲ 9.10% |
| Market cap | $6.24B | $6.24B |
| Return, 3 months | -3.8% | +128.8% |
| Return, year to date | +19.0% | +255.2% |
| Return, 1 year | +28.1% | +463.2% |
| P/E (TTM) | 9.7 | – |
| P/B | 1.2 | 102.2 |
| P/E percentile vs own 5y | 96th | 1st |
| Dividend yield | 1.94% | – |
| Revenue growth (YoY, latest qtr) | +4.2% | – |
| Net profit growth (YoY) | +4.2% | -20.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 54.5% | – |
| Return on equity | 12.9% | -368.4% |
| Analyst target vs. price | -0.4% | +22.1% |
| Analyst buy share | 0% | 86% |
| RSI (14) | 46 | 62 |
| 30-day volatility | 32.7% | 305.1% |
| Max drawdown, 1 year | -13.6% | -36.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ACT is the largest of the group by market value.
- KOD has returned the most over the past year.
- ACT has been the calmest stock over the last 30 days.